Back to results
US 2003/0113270 A1Published application
Vasoactive intestinal peptides for glaucomatous retinopathy
OwnerAbbot F. Clarkinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for treatment of glaucoma and other retinal diseases comprising the use of compositions containing vasoactive intestinal peptides.
Claims4
A method for the protection of retinal ganglion cells in glaucomatous optic neuropathy, said method comprising administering to a patient in need thereof a pharmaceutically effective amount of a composition comprising a vasoactive intestinal peptide or an analog thereof.
Dependencies are inferred from the claim text.